The application ofLTDs carrying cytotoxic drugs is gaining favor in the anticancer drugdevelopment because it minimizes side effects of the original cytotoxicdrug.,,,, PSMA has been the targetof choice for the development of LTDs against PCa, due to its vastexpression in the PCa cell surface and ability to internalize thecarried load inside the cell. Here, FOLH1 is linked to posterior cortical atrophy.